Patient prioritisation in current practice of Brazilian hospital clinical pharmacist: a cross-sectional survey

Stephanie Ferreira  BOTELHO; Lais Lessa  NEIVA-PANTUZZA; Adriano Max  REIS

doi:10.30968/jhphs.2025.161.1232

Autores

Stephanie Ferreira BOTELHO https://orcid.org/0000-0002-6301-4683
Lais Lessa NEIVA-PANTUZZA https://orcid.org/0000-0001-9831-8807
Adriano Max REIS https://orcid.org/0000-0002-0017-7338

DOI:

https://doi.org/10.30968/jhphs.2025.161.1232

Resumo

Objetivo: Pesquisar a inserção da priorização de pacientes na prática atual de farmacêuticos clínicos em hospitais brasileiros e analisar a utilidade dos critérios de priorização de pacientes para farmácia clínica desenvolvidos em um estudo Delphi com Farmacêuticos clínicos. Métodos: Trata-se de um estudo transversal, survey online. Os autores elaboraram o questionário da pesquisa com base em estudos publicados na literatura. Farmacêuticos hospitalares de todo o Brasil foram convidados a participar do survey. Os autores adotaram a estratégia de amostragem bola de neve para replicar o questionário nas redes sociais. Resultados: Um total de 149 farmacêuticos concordaram em participar da pesquisa. Na prática clínica, 94 (63,1%) participantes usaram critérios de priorização para selecionar pacientes para cuidados de farmácia clínica, e 55 (36,9%) empregaram priorização na prática clínica usando uma interface com sistema computadorizado do hospital. Oitenta e nove (74,2%) das 120 avaliações de critérios/subcritérios avaliados quanto à sua aplicabilidade na prática clínica obtiveram concordância acima de 70%. Conclusão: A priorização de pacientes para serviços de farmácia clínica é frequentemente usada na prática clínica de farmacêuticos participantes do survey. Priorização de pacientes para serviços de farmácia clínica integrada ao sistema informatizado do hospital é um facilitador para incorporação da priorização na prática clínica. Disponibilidade de informações e coleta de dados acessíveis são relevantes para que o critério seja usado para priorização de pacientes para farmácia clínica.

Downloads

Não há dados estatísticos.

Referências

Geeson C, Wei L, Franklin BD. High-risk medicines associated with clinically relevant medication-related problems in UK hospitals: A prospective observational study. Br J Clin Pharmacol. 2020;86(1):165-169. doi:10.1111/bcp.14119

Alshakrah MA, Steinke DT, Lewis PJ. Patient prioritization for pharmaceutical care in hospital: A systematic review of assessment tools [published correction appears in Res Social Adm Pharm. 2020 Jul;16(7):993. doi: 10.1016/j.sapharm.2020.04.010.]. Res Social Adm Pharm. 2019;15(6):767-779. doi:10.1016/j.sapharm.2018.09.009

Abuzour AS, Hoad-Reddick G, Shahid M, et al. Patient prioritisation for hospital pharmacy services: current approaches in the UK. Eur J Hosp Pharm. 2021;28(Suppl 2):e102-e108. doi:10.1136/ejhpharm-2020-002365

Falconer N, Barras M, Cottrell N. How hospital pharmacists prioritise patients at high-risk for medication harm. Res Social Adm Pharm. 2019;15(10):1266-1273. doi:10.1016/j.sapharm.2018.11.003

Santos Júnior GAD, Ramos SF, Pereira AM, et al. Perceived barriers to the implementation of clinical pharmacy services in a metropolis in Northeast Brazil. PLoS One. 2018;13(10):e0206115. Published 2018 Oct 22. doi:10.1371/journal.pone.0206115

Flynn A, Mo H, Nguyen JV, et al. Initial study of clinical pharmacy work prioritization tools. Am J Health Syst Pharm. 2018;75(15):1122-1131. doi:10.2146/ajhp170398

Martinbiancho JK, Zuckermann J, Mahmud SD, et al. Development of Risk Score to Hospitalized Patients for Clinical Pharmacy Rationalization in a High Complexity Hospital. Am J Health Syst Pharm. 2011;30:1342-1349.

Geeson C, Wei L, Franklin BD. Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists’ input to improve patient outcomes. Protocol for an observational study [published correction appears in BMJ Open. 2017 Aug 1;7(7):e017509corr1. doi: 10.1136/bmjopen-2017-017509corr1.]. BMJ Open. 2017;7(6):e017509. Published 2017 Jun 14. doi:10.1136/bmjopen-2017-017509.

Schepel L, Aronpuro K, Kvarnström K, et al. Strategies for improving medication safety in hospitals: Evolution of clinical pharmacy services. Res Social Adm Pharm. 2019;15(7):873-882. doi:10.1016/j.sapharm.2019.02.004.

Geeson C, Wei L, Franklin BD. Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists’ input to prevent medication-related problems. BMJ Qual Saf. 2019;28(8):645-656. doi:10.1136/bmjqs-2018-008335

Botelho SF, Neiva Pantuzza LL, Marinho CP, et al. Prognostic prediction models and clinical tools based on consensus to support patient prioritization for clinical pharmacy services in hospitals: A scoping review. Res Social Adm Pharm. 2021;17(4):653-663. doi:10.1016/j.sapharm.2020.08.002.

Santos TR, Penm J, Baldoni AO, et al. Hospital pharmacy workforce in Brazil. Hum Resour Health. 2018; 16:1 doi: 10.1186/s12960-021-00680-2

Botelho SF, Pantuzza LLN, Marinho CP, Reis AMM. Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study. Int J Clin Pharm. 2022;44(4):985-992. doi:10.1007/s11096-022-01424-5.

Lima TM, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients. Res Social Adm Pharm. 2019;15(9):1080-1087. doi:10.1016/j.sapharm.2018.09.010

Vila Torres E, Pérez Anchordoqui D, Porta Oltra B, et al. Modelo predictivo preliminar para la identificación de pacientes con oportunidades de mejora farmacoterapéutica [Preliminary prediction model for identifying patients with the possibility of pharmacotherapy improvement]. Farm Hosp. 2010;34(6):298-302. doi:10.1016/j.farma.2010.01.006

Urbina O, Ferrández O, Grau S, et al. Design of a score to identify hospitalized patients at risk of drug-related problems. Pharmacoepidemiol Drug Saf. 2014;23(9):923-932. doi:10.1002/pds.3634.

Falconer N, Barras M, Cottrell N. Systematic review of predictive risk models for adverse drug events in hospitalized patients. Br J Clin Pharmacol. 2018;84(5):846-864. doi:10.1111/bcp.13514

Dos Santos Barreto PG, Barbosa Rezende R, Dos Santos AL, et al. Fully independent validation and updating of a clinical pharmacy prioritizing risk score in an infectious disease hospital ward. Br J Clin Pharmacol. 2022;88(8):3695-3708. doi:10.1111/bcp.15312.

Hohmeier KC, McDonough SLK, Rein LJ, Brookhart AL, Gibson ML, Powers MF. Exploring the expanded role of the pharmacy technician in medication therapy management service implementation in the community pharmacy. J Am Pharm Assoc (2003). 2019;59(2):187-194. doi:10.1016/j.japh.2018.11.006.

Hohmeier KC, Shelton C, Havrda D, et al. The need to prioritize “prioritization” in clinical pharmacy service practice and implementation. Res Social Adm Pharm. 2020;16(12):1785-1788. doi:10.1016/j.sapharm.2020.04.012.

Wolff RF, Moons KGM, Riley RD, et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med. 2019;170(1):51-58. doi:10.7326/M18-1376.

Falconer N, Barras M, Abdel-Hafez A, Radburn S, Cottrell N. Development and validation of the Adverse Inpatient Medication Event model (AIME). Br J Clin Pharmacol. 2021;87(3):1512-1524. doi:10.1111/bcp.14560.

Serafin, C, Junior DC, Vargas M .Perfil do farmacêutico no Brasil: relatório – Brasília: Conselho Federal de Farmácia, 2015, 44 p.

Melo AC, Galato D, Maniero HK, et al. Pharmacy in Brazil: Progress and Challenges on the Road to Expanding Clinical Practice. Can J Hosp Pharm. 2017;70(5):381-390. doi:10.4212/cjhp.v70i5.1700.